# Northwest Biotherapeutics Inc: Form DEF 14A, filed Dec 5, 2022

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: DEF 14A
- Filed: 2022-12-05
- Accepted by EDGAR: Dec 5, 2022, 07:00 ET
- Period: 2022-12-30
- Accession: 0001104659-22-124360
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465922124360/tm2231325-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465922124360/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465922124360/tm2231325-2_def14a.htm

Filed Dec 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-124360. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.